Marlene Wright Barton
Präsident bei Wright Regulatory Consulting LLC
Aktive Positionen von Marlene Wright Barton
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital LLC (Revival Healthcare Capital) is a private equity firm founded in 2018 by justin Ballotta. The firm is headquartered in Austin, Texas. | Berater | - | - |
Syncromune, Inc.
Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020. | Compliance Officer | 01.12.2021 | - |
Corporate Officer/Principal | 01.12.2021 | - | |
Wright Regulatory Consulting LLC | Präsident | 01.09.2020 | - |
WRC LLC | Präsident | 01.01.2010 | - |
Karriereverlauf von Marlene Wright Barton
Ehemalige bekannte Positionen von Marlene Wright Barton
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ImmunSYS, Inc.
ImmunSYS, Inc. Pharmaceuticals: MajorHealth Technology ImmunSYS, Inc. is a clinical stage biopharmaceutical company focused on the development of cancer immunotherapy products. The company was founded by Eamonn P. Hobbs and Charles J. Link Jr. in March 2018 and is headquartered in Fort Lauderdale, FL. | Compliance Officer | 01.10.2018 | 01.09.2020 |
Corporate Officer/Principal | 01.10.2018 | 01.09.2020 | |
PTV Sciences LP
PTV Sciences LP Investment ManagersFinance PTV Sciences LP (PTV Healthcare Capital) is a venture capital firm founded in 2003 by Matthew S. Crawford and Evan S. Melrose. The firm is headquartered in Houston, Texas. | Private Equity Investor | - | - |
Ausbildung von Marlene Wright Barton
SUNY Empire State College | Graduate Degree |
State University of New York at Binghamton | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Israel | 2 |
Operativ
Compliance Officer | 2 |
Corporate Officer/Principal | 2 |
President | 2 |
Sektoral
Finance | 3 |
Consumer Services | 3 |
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 6 |
---|---|
PTV Sciences LP
PTV Sciences LP Investment ManagersFinance PTV Sciences LP (PTV Healthcare Capital) is a venture capital firm founded in 2003 by Matthew S. Crawford and Evan S. Melrose. The firm is headquartered in Houston, Texas. | Finance |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital LLC (Revival Healthcare Capital) is a private equity firm founded in 2018 by justin Ballotta. The firm is headquartered in Austin, Texas. | Finance |
Syncromune, Inc.
Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020. | Health Technology |
ImmunSYS, Inc.
ImmunSYS, Inc. Pharmaceuticals: MajorHealth Technology ImmunSYS, Inc. is a clinical stage biopharmaceutical company focused on the development of cancer immunotherapy products. The company was founded by Eamonn P. Hobbs and Charles J. Link Jr. in March 2018 and is headquartered in Fort Lauderdale, FL. | Health Technology |
Wright Regulatory Consulting LLC | |
WRC LLC |
- Börse
- Insiders
- Marlene Wright Barton
- Erfahrung